Status:
COMPLETED
Influence of Obstructive Sleep Apnea on the Severity of Coronary Artery Disease
Lead Sponsor:
Chinese Pulmonary Vascular Disease Research Group
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
35-75 years
Brief Summary
It is widely accepted that coronary artery disease (CAD) is related to a high mortality. It is predicted that an increase of approximately 21.3 million cardiovascular events and 7.7 million cardiovasc...
Detailed Description
Before initiating the study, all potential subjects were invited to attend an educational program that explained the purpose and methodology of this study. After getting informed consent from patients...
Eligibility Criteria
Inclusion
- aged 35 to 75 years with CAD
- CAD was verified by coronary angiography
Exclusion
- Patients had New York Heart Association Class III-IV degree with ejection fraction \< 45%
- Severe pulmonary disease
- Significant psychiatric disease
- History of pharyngeal surgery for OSA or current use of CPAP treatment for OSA
- Subjects declined to participate or were unable to provide informed consent.
Key Trial Info
Start Date :
February 14 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 29 2019
Estimated Enrollment :
255 Patients enrolled
Trial Details
Trial ID
NCT04741022
Start Date
February 14 2017
End Date
August 29 2019
Last Update
February 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
center of pulmonary vascular disease, Fuwai hospital
Beijing, China, 100037